No Data
No Data
Beijing Scitop Bio-tech: Summary of Half-Year Report in 2024.
Beijing Scitop Bio-tech: Half-year report for the year 2024.
Beijing Scitop Bio-Tech (300858.SZ) released its semi-annual performance, with a net income of 43.51 million yuan, a year-on-year increase of 7.89%.
Beijing Scitop Bio-tech (300858.SZ) released its 2024 interim report, with the company achieving a revenue of 1.38...
Beijing Scitop Bio-Tech (300858.SZ): Inner Mongolia Scitop received a government subsidy of 20 million yuan.
Beijing Scitop Bio-tech (300858.SZ) announced on August 13th that its wholly-owned subsidiary Inner Mongolia Scitop Bio-Tech Co., Ltd. (referred to as Inner Mongolia Scitop) recently received government subsidies of RMB 20 million, accounting for 21.39% of the net income attributable to shareholders of the listed company in 2023 as audited.
Beijing Scitop Bio-Tech (300858.SZ): The company and its wholly-owned subsidiaries have received 8 patent certificates.
On July 17th, Gelon Hui reported that Beijing Scitop Bio-Tech (300858.SZ) and its wholly-owned subsidiaries Jinhua Silver Galaxy Biotechnology Co. Ltd. (hereinafter referred to as "Jinhua Silver Galaxy") and Inner Mongolia Scitop Biotech Co. Ltd. (hereinafter referred to as "Inner Mongolia Scitop") have recently received 8 patent certificates issued by the National Intellectual Property Office. The patent titles are respectively a probiotic composition and its application, a long bifidobacterium strain that promotes calcium absorption and its application, and the use of B2798, a short bifidobacterium strain, to prepare probiotic preparations, etc.
Beijing Scitop Bio-tech (300858.SZ) won the second prize of National Science and Technology Progress Award.
Beijing Scitop Bio-tech (300858.SZ) announced that the company participated in the key project of discovering and industrializing excellent lactic acid bacteria germplasm resources…
No Data
No Data